- Open Access
Erratum to: Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells
Cancer Cell International volume 17, Article number: 53 (2017)
Erratum to: Cancer Cell Int (2016) 16:19 DOI 10.1186/s12935-016-0292-7
Upon publication of the original article , it was noted that the Core Facilities utilized by the authors for their research were not adequately acknowledged in the manuscript. In this case, the following was mistakenly omitted:
Progenitor cell analysis core
Molecular Phenotyping core
Stem Cell COBRE Grant P30GM106391
Vascular Biology COBRE Grant P30GM103392
This has since been acknowledged and corrected in this erratum.
Jing H, Liaw L, Friesel R, Vary C, Hua S, Yang X. Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells. Cancer Cell Int. 2016;16(1):19. doi:10.1186/s12935-016-0292-7.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found under doi:10.1186/s12935-016-0292-7.
About this article
Cite this article
Jing, H., Liaw, L., Friesel, R. et al. Erratum to: Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells. Cancer Cell Int 17, 53 (2017). https://doi.org/10.1186/s12935-017-0423-9